Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Journal of Interventional Cardiac Electrophysiology
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2013

01.03.2013

US Health Care Policy and Reform: implications for cardiac electrophysiology

verfasst von: Mintu P. Turakhia, Aditya J. Ullal

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

In response to unsustainably rising costs, variable quality and access to health care, and the projected insolvency of vital safety net insurance programs, the federal government has proposed important health policy and regulatory changes in the USA. The US Supreme Court’s decision to uphold most of the major provisions of the Affordable Care Act will lead to some of the most sweeping government reforms on entitlements since the creation of Medicare. Furthermore, implementation of new organizational, reimbursement, and health care delivery models will strongly affect the practice of cardiac electrophysiology. In this brief review, we will provide background and context to the problem of rising health care costs and describe salient reforms and their projected impacts on the field and practice of cardiac electrophysiology.
Literatur
1.
Anderson, G. F., Reinhardt, U. E., Hussey, P. S., & Petrosyan, V. (2003). It’s the prices, stupid: why the United States is so different from other countries. Health Affair(Millwood), 22(3), 89–105.CrossRef
2.
Martin, A. B., Lassman, D., Washington, B., & Catlin, A. (2012). Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009. Health Affair (Millwood), 31(1), 208–219.CrossRef
3.
4.
Glied, S. A. (2003). Health insurance and market failure since arrow. In P. J. Hammer, D. Haas-Wilson, M. A. Peterson, & W. M. Sage (Eds.), Uncertain times: Kenneth Arrow and the changing economics of health care (pp. 49–59). Durham: Duke University Press Books.
5.
6.
Schoen, C., Osborn, R., Doty, M. M., Bishop, M., Peugh, J., & Murukutla, N. (2007). Toward higher-performance health systems: adults’ health care experiences in seven countries, 2007. Health Affair (Millwood), 26(6), w717–734.CrossRef
7.
Garber, A. M., & Skinner, J. (2008). Is American health care uniquely inefficient? Journal of Economic Perspectives, 22(4), 27–50.PubMedCrossRef
8.
Woolhandler, S., Campbell, T., & Himmelstein, D. U. (2003). Costs of health care administration in the United States and Canada. The New England Journal of Medicine, 349(8), 768–775.PubMedCrossRef
9.
10.
Jacobs, L. R. (2007). The Medicare approach: political choice and American institutions. Journal of Health Politics, Policy and Law, 32(2), 159–186.PubMedCrossRef
11.
12.
13.
Kociol, R. D., Greiner, M. A., Fonarow, G. C., Hammill, B. G., Heidenreich, P. A., Yancy, C. W., et al. (2011). Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. The American Journal of Cardiology, 108(7), 985–991.PubMedCrossRef
14.
Vidovich, M. I., Vasaiwala, S., Cannon, C. P., Peterson, E. D., Dai, D., Hernandez, A. F., et al. (2010). Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. American Heart Journal, 159(6), 1026–1036.PubMedCrossRef
15.
Lucas, F. L., Sirovich, B. E., Gallagher, P. M., Siewers, A. E., & Wennberg, D. E. (2010). Variation in cardiologists’ propensity to test and treat: is it associated with regional variation in utilization? Circulation. Cardiovascular Quality and Outcomes, 3(3), 253–260.PubMedCrossRef
16.
Parker, L., Levin, D. C., Frangos, A., & Rao, V. M. (2010). Geographic variation in the utilization of noninvasive diagnostic imaging: national medicare data, 1998–2007. AJR. American Journal of Roentgenology, 194(4), 1034–1039.PubMedCrossRef
17.
Coyne, K. S., Paramore, C., Grandy, S., Mercader, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9(5), 348–356.PubMedCrossRef
18.
Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., et al. (2010). Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation, 121(7), 948–954.PubMedCrossRef
19.
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., et al. (2006). Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation, 114(2), 119–125.PubMedCrossRef
20.
Cutler, D. M., Rosen, A. B., & Vijan, S. (2006). The value of medical spending in the United States, 1960–2000. The New England Journal of Medicine, 355(9), 920–927.PubMedCrossRef
21.
Goedert, J. (2011). Sorting through Medicare RAC audits. Health Data Management, 19(3), 34–36. 38–39.
22.
American Recovery and Reinvestment Act (ARRA) (2009). Pub. L. No. 111–5, §§ 13101–13424, 123 Stat. 115, 228–279.
23.
24.
Hsiao, C., Hing, E., Socey, T.C., & Cai, B. (2011). Electronic health record systems and intent to apply for meaningful use incentives among office-based physician practices: United States, 2001–2011. NCHS data brief. Hyattsville (MD): National Center for Health Statistics.
25.
McCormick, D., Bor, D. H., Woolhandler, S., & Himmelstein, D. U. (2012). Giving office-based physicians electronic access to patients’ prior imaging and lab results did not deter ordering of tests. Health Aff (Millwood), 31(3), 488–496.CrossRef
26.
27.
28.
29.
Pear, R. (2012, March 23). House votes to kill a Medicare cost panel. New York Times, p. A13.
30.
31.
Ip, S., Terasawa, T., Balk, E.M., Chung, M., Alsheikh-Ali, A.A., Garlitski, A.C., et al. (2009). Comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation. AHRQ Comparative Effectiveness Reviews, publication no.09-EHC015-EF [book accession].
32.
Perlroth, D. J., Goldman, D. P., & Garber, A. M. (2010). The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography, 47(Suppl), S173–190.PubMedCrossRef
33.
Addicott, R. (2012). What accountable care organizations will mean for physicians. BMJ, 345, e6461.PubMedCrossRef
34.
Ginsburg, P. B. (2012). Fee-for-service will remain a feature of major payment reforms, requiring more changes in Medicare physician payment. Health Affair (Millwood), 31(9), 1977–1983.CrossRef
35.
36.
37.
Stratienko, A. A. (2011). The practice of cardiology and healthcare reform. Journal of the American College of Cardiology, 57(21), 2139–2140.PubMedCrossRef
38.
39.
Heidenreich, P. A., Sahay, A., Kapoor, J. R., Pham, M. X., & Massie, B. (2010). Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. Journal of the American College of Cardiology, 56(5), 362–368.PubMedCrossRef
40.
Hammill, S. C., & Curtis, J. (2008). Publicly reporting implantable cardioverter defibrillator outcomes: grading the report card. Circulation. Arrhythmia and Electrophysiology, 1(4), 235–237.PubMedCrossRef
41.
Joynt, K. E., Blumenthal, D. M., Orav, E. J., Resnic, F. S., & Jha, A. K. (2012). Association of public reporting for percutaneous coronary intervention with utilization and outcomes among Medicare beneficiaries with acute myocardial infarction. Journal of the American Medical Association, 308(14), 1460–1468.PubMedCrossRef
42.
Jha, A. K., Joynt, K. E., Orav, E. J., & Epstein, A. M. (2012). The long-term effect of premier pay for performance on patient outcomes. The New England Journal of Medicine, 366(17), 1606–1615.PubMedCrossRef
43.
Werner, R. M., & Dudley, R. A. (2012). Medicare’s new hospital value-based purchasing program is likely to have only a small impact on hospital payments. Health Affair (Millwood), 31(9), 1932–1940.CrossRef
44.
45.
Al-Khatib, S. M., Hellkamp, A., Curtis, J., Mark, D., Peterson, E., Sanders, G. D., et al. (2011). Non-evidence-based ICD implantations in the United States. Journal of the American Medical Association, 305(1), 43–49.PubMedCrossRef
46.
Steinberg, J. S., & Mittal, S. (2012). The federal audit of implantable cardioverter-defibrillator implants: lessons learned. Journal of the American College of Cardiology, 59(14), 1270–1274.PubMedCrossRef
47.
48.
49.
50.
Cutler, D. M., & Ghosh, K. (2012). The potential for cost savings through bundled episode payments. The New England Journal of Medicine, 366(12), 1075–1077.PubMedCrossRef
51.
US Department of Health and Human Services. (2011). Medicare shared savings programs: accountable care organizations and Medicare program. Federal Register, 76(67).
52.
Metadaten
Titel
US Health Care Policy and Reform: implications for cardiac electrophysiology
verfasst von
Mintu P. Turakhia
Aditya J. Ullal
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2013
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-012-9773-3

Weitere Artikel der Ausgabe 2/2013

Journal of Interventional Cardiac Electrophysiology 2/2013 Zur Ausgabe

OriginalPaper

Volume, outcome, and policy

OriginalPaper

Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy

Reviews

Prediction and prevention of sudden death in young populations: the role of ECG screening

EDITOR’S FORUM

Foreword: health policy and cardiac electrophysiology

OriginalPaper

The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis

OriginalPaper

Health care policy and regulatory implications on medical device innovations: a cardiac rhythm medical device industry perspective

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise